TWOEquity · Weekly research terminal

7427

Great Novel Therapeutics Biotech & Medicals

TW Healthcare Biotechnology

Latest week
14 Aug 2026
Weekly close
71.50 TWD
Fair value
45.44 TWD
Next-week expectancy
Negative 42.52%
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TWO · Equity · Taiwan

7427

Great Novel Therapeutics Biotech & Medicals

Healthcare Biotechnology

Great Novel Therapeutics Biotech & Medicals engages in the development of drugs for the treatment of advanced and refractory cancers in Taiwan. The company develops GNTbm-38, an epigenetic immune-activating drug independently developed by GNTbm for cancer immunotherapy; and GNTbm-TKI, a potent inhibitor of TYRO-3, AXL, c-MER, BTK, ROS1, NTRK2, MET, and VEGFR2 for immune regulation, tumor growth inhibition, metastasis and invasion suppresion, and anti-angiogenesis activity. It is also developing Kepida to treat …

Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Biotechnology
Currency
TWD
Market capitalisation
3,781,597,440
Fair value reference
45.44
Next-week expectancy
Negative · 42.52%

Over the latest 12 completed weeks ending 2026-08-14, 7427 rose 85.71%, moving from 38.50 to 71.50. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 36.32 and has improved across the 12-week window. Market Dynamics is 1.53 on the latest week. Next-week expectancy is negative at 42.52% based on similar historical setup states.

Week Ending
14 Aug 2026
Latest Close
71.50
12-Week Change
85.71%
Trend Signal
Active
Next-Week Expectancy
Negative 42.52%
Signal Weeks
12 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
14 Aug 2026
Latest Close
71.50
12-Week Change
85.71%
Trend Signal
Active
Next-Week Expectancy
Negative 42.52%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
36.32
Market Dynamics
1.53

Over the latest 12 completed weeks ending 2026-08-14, 7427 rose 85.71%, moving from 38.50 to 71.50. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 36.32 and has improved across the 12-week window. Market Dynamics is 1.53 on the latest week. Next-week expectancy is negative at 42.52% based on similar historical setup states.

Industry Peers

Taiwan equities in Biotechnology

Stock Exchange Week Open High Low Close Change
6696 Lin BioScience, Inc. TWO 14 Aug 2026 708.00 930.00 684.00 912.00 28.81%
7832 Intelligene TWO 14 Aug 2026 11.75 13.55 11.75 13.55 15.32%
6949 Pell Bio-Med Technology Co., Ltd. TAI 14 Aug 2026 943.00 1090.00 914.00 1070.00 13.47%
6848 RBC Bioscience Corporation TWO 14 Aug 2026 19.05 23.45 19.05 21.55 13.12%
4147 TaiMed Biologics Inc. TWO 14 Aug 2026 58.30 69.80 58.20 64.20 10.12%
6810 Bio Preventive Medicine Corp. TWO 14 Aug 2026 21.05 24.15 20.70 23.05 9.50%
7776 Anya TWO 14 Aug 2026 30.00 33.15 29.85 32.50 8.33%
6945 AP Biosciences, Inc. TWO 14 Aug 2026 99.00 116.50 99.00 104.50 5.56%
6492 Senhwa Biosciences, Inc. TWO 14 Aug 2026 37.50 39.65 36.90 38.80 3.47%
4732 NatureWise Biotech & Medicals Corporation TWO 14 Aug 2026 15.95 16.70 15.90 16.50 3.45%
7827 HanchorBio Inc. TAI 14 Aug 2026 156.00 164.50 153.50 161.00 3.21%
7773 FullHope TWO 14 Aug 2026 26.30 27.10 25.90 27.10 3.04%
4911 G&E Herbal Biotechnology Co., Ltd. TWO 14 Aug 2026 28.00 28.95 28.00 28.85 3.04%
7837 Creative TWO 14 Aug 2026 70.00 72.10 70.00 72.10 3.00%
7725 LabTurbo Biotech Corporation TWO 14 Aug 2026 21.70 22.30 21.70 22.30 2.76%
6589 EirGenix Inc. TAI 14 Aug 2026 50.20 52.90 50.00 51.50 2.59%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context